Deacetylation of FOXP1 by HDAC7 potentiates self-renewal of mesenchymal stem cells

[1]  Shengbing Yang,et al.  FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53 , 2021, Oncogene.

[2]  J. Qu,et al.  SIRT3 consolidates heterochromatin and counteracts senescence , 2021, Nucleic acids research.

[3]  F. Chen,et al.  Human amnion-derived mesenchymal stem cells improved the reproductive function of age-related diminished ovarian reserve in mice through Ampk/FoxO3a signaling pathway , 2021, Stem Cell Research & Therapy.

[4]  J. C. Belmonte,et al.  FOXO3-engineered human mesenchymal progenitor cells efficiently promote cardiac repair after myocardial infarction , 2020, Protein & Cell.

[5]  J. Qu,et al.  SIRT7 antagonizes human stem cell aging as a heterochromatin stabilizer , 2020, Protein & Cell.

[6]  L. Montoliu,et al.  Simple Protocol for Generating and Genotyping Genome‐Edited Mice With CRISPR‐Cas9 Reagents , 2020, Current protocols in mouse biology.

[7]  Jeong-Sun Kim,et al.  A short guide to histone deacetylases including recent progress on class II enzymes , 2020, Experimental & Molecular Medicine.

[8]  Haley O. Tucker,et al.  Foxp1 Regulates Neural Stem Cell Self-Renewal and Bias Toward Deep Layer Cortical Fates. , 2020, Cell reports.

[9]  Sung-Hoon Kim,et al.  Molecular networks of FOXP family: dual biologic functions, interplay with other molecules and clinical implications in cancer progression , 2019, Molecular Cancer.

[10]  M. Longaker,et al.  A Revised Perspective of Skeletal Stem Cell Biology , 2019, Front. Cell Dev. Biol..

[11]  J. I. Izpisúa Belmonte,et al.  FOXO3-Engineered Human ESC-Derived Vascular Cells Promote Vascular Protection and Regeneration. , 2019, Cell stem cell.

[12]  Haley O. Tucker,et al.  Foxp1 Is Indispensable for Ductal Morphogenesis and Controls the Exit of Mammary Stem Cells from Quiescence. , 2018, Developmental cell.

[13]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[14]  Rachel E. Brewer,et al.  Identification of the Human Skeletal Stem Cell , 2018, Cell.

[15]  D. Landau,et al.  Discovery of a periosteal stem cell mediating intramembranous bone formation , 2018, Nature.

[16]  Wei Liu,et al.  Sirtuin3 protects aged human mesenchymal stem cells against oxidative stress and enhances efficacy of cell therapy for ischaemic heart diseases , 2018, Journal of cellular and molecular medicine.

[17]  K. Zainabadi.  The variable role of SIRT1 in the maintenance and differentiation of mesenchymal stem cells. , 2018, Regenerative medicine.

[18]  C. Colnot,et al.  Periosteum contains skeletal stem cells with high bone regenerative potential controlled by Periostin , 2018, Nature Communications.

[19]  H. Mefford,et al.  Prospective investigation of FOXP1 syndrome , 2017, Molecular Autism.

[20]  Ryan A. Denu,et al.  SIRT3 Enhances Mesenchymal Stem Cell Longevity and Differentiation , 2017, Oxidative medicine and cellular longevity.

[21]  I. Dusanter-Fourt,et al.  PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells. , 2017, Blood.

[22]  Haley O. Tucker,et al.  FOXP1 controls mesenchymal stem cell commitment and senescence during skeletal aging , 2017, The Journal of clinical investigation.

[23]  E. Ballestar,et al.  In vivo conditional deletion of HDAC7 reveals its requirement to establish proper B lymphocyte identity and development , 2016, The Journal of experimental medicine.

[24]  Haley O. Tucker,et al.  Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1 , 2016, Proceedings of the National Academy of Sciences.

[25]  D. Guan,et al.  SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2 , 2016, Cell Research.

[26]  Su In Lee,et al.  FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells , 2015, Oncotarget.

[27]  B. Morris,et al.  FOXO3: A Major Gene for Human Longevity - A Mini-Review , 2015, Gerontology.

[28]  A. Deal,et al.  FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma , 2015, Science Signaling.

[29]  D. Sahoo,et al.  Identification and Specification of the Mouse Skeletal Stem Cell , 2015, Cell.

[30]  Yoorim Choi,et al.  SIRT1 Directly Regulates SOX2 to Maintain Self‐Renewal and Multipotency in Bone Marrow‐Derived Mesenchymal Stem Cells , 2014, Stem cells.

[31]  F. Berthold,et al.  FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma , 2014, BMC Cancer.

[32]  Haley O. Tucker,et al.  Foxp1 maintains hair follicle stem cell quiescence through regulation of Fgf18 , 2013, Development.

[33]  K. McBride,et al.  Genetic Abnormalities in FOXP1 Are Associated with Congenital Heart Defects , 2013, Human mutation.

[34]  Ling-bo Cai,et al.  Normal human embryonic stem cell lines were derived from microsurgical enucleated tripronuclear zygotes , 2013, Journal of cellular biochemistry.

[35]  L. Guarente,et al.  The NAD+/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling , 2013, Cell.

[36]  S. Morrison,et al.  Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches , 2013, Nature.

[37]  D. Link,et al.  CXCL12 Production by Early Mesenchymal Progenitors is Required for Hematopoietic Stem Cell Maintenance , 2012, Nature.

[38]  X. Pei,et al.  SIRT1 is required for long-term growth of human mesenchymal stem cells , 2012, Journal of Molecular Medicine.

[39]  E. Verdin,et al.  Three Novel Acetylation Sites in the Foxp3 Transcription Factor Regulate the Suppressive Activity of Regulatory T Cells , 2012, The Journal of Immunology.

[40]  Song He,et al.  Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma , 2012, Journal of Clinical Pathology.

[41]  S. Shi,et al.  Mesenchymal Stem Cell-Based Tissue Regeneration is Governed by Recipient T Lymphocyte via IFN-γ and TNF-α , 2011, Nature Medicine.

[42]  Jeffrey L. Wrana,et al.  An Alternative Splicing Switch Regulates Embryonic Stem Cell Pluripotency and Reprogramming , 2011, Cell.

[43]  Haikun Wang,et al.  Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells , 2011, Nature Immunology.

[44]  R. Evans,et al.  Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis , 2011, Cell.

[45]  Chia-Hao Chang,et al.  Solution structure and backbone dynamics of the DNA‐binding domain of FOXP1: Insight into its domain swapping and DNA binding , 2011, Protein science : a publication of the Protein Society.

[46]  E. Fombonne,et al.  De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. , 2010, American journal of human genetics.

[47]  A. Monaco,et al.  Assessing the impact of FOXP1 mutations on developmental verbal dyspraxia , 2009, European Journal of Human Genetics.

[48]  S. Fox,et al.  Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptorβ in primary invasive breast carcinomas , 2008, Breast Cancer Research and Treatment.

[49]  R. Zhao,et al.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell Stem Cell.

[50]  J. Westendorf,et al.  Histone Deacetylase 7 Associates With Runx2 and Represses Its Activity During Osteoblast Maturation in a Deacetylation‐Independent Manner , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[51]  M. Blasco,et al.  Cellular Senescence in Cancer and Aging , 2007, Cell.

[52]  A. Banham,et al.  FOXP1: a potential therapeutic target in cancer , 2007, Expert opinion on therapeutic targets.

[53]  Yuan Shen,et al.  FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression , 2007, Proceedings of the National Academy of Sciences.

[54]  E. Olson,et al.  Histone Deacetylase 7 Maintains Vascular Integrity by Repressing Matrix Metalloproteinase 10 , 2006, Cell.

[55]  J. Nardone,et al.  Foxp1 is an essential transcriptional regulator of B cell development , 2006, Nature Immunology.

[56]  Moustapha Hassan,et al.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells , 2004, The Lancet.

[57]  Steven P. Gygi,et al.  Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase , 2004, Science.

[58]  Shanru Li,et al.  Transcriptional and DNA Binding Activity of the Foxp1/2/4 Family Is Modulated by Heterotypic and Homotypic Protein Interactions , 2004, Molecular and Cellular Biology.

[59]  Diana van Heemst,et al.  Insulin, IGF-1 and longevity. , 2010, Aging and disease.

[60]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..